+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Resuscitative Endovascular Balloon Occlusion Of The Aorta Market Size, Share & Trends Analysis Report By End-use (Cardiac Arrest, Aortic Occlusion, Tactical Combat Casualty Care), By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 120 Pages
  • August 2024
  • Region: Global
  • Grand View Research
  • ID: 5998866

Market Size & Trends

The global resuscitative endovascular balloon occlusion of the aorta market size was valued at USD 9.58 million in 2023 and is projected to grow at a CAGR of 19.9% from 2024 to 2030. The market is driven by several key factors that influence its growth and adoption in clinical settings. These drivers include the increasing prevalence of traumatic injuries, advancements in medical technology, a growing emphasis on trauma care protocols, rising awareness among healthcare professionals, and supportive government initiatives. Each of these elements plays a crucial role in shaping the market landscape and enhancing the utilization of REBOA as a life-saving intervention.

The rising incidence of traumatic injuries, particularly those resulting from road accidents, falls, and violence, is a significant driver for the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) market. As trauma cases often lead to hemorrhagic shock, the demand for effective resuscitation techniques has surged. REBOA provides a minimally invasive option that can be rapidly deployed in emergency situations, making it an attractive choice for trauma surgeons and emergency medical services. In June 2024, the World Health Organization reported that injuries, both unintentional and violence-related, significantly contribute to trauma, leading to 4.4 million deaths annually. Exposure to trauma, especially during childhood, can heighten the risk of mental health issues, substance abuse, chronic diseases, and social problems.

Technological advancements in medical devices have significantly enhanced the efficacy and safety of REBOA procedures. Innovations such as improved balloon designs, better catheter systems, and enhanced imaging technologies facilitate more precise placement and monitoring during procedures. These advancements not only improve patient outcomes but also encourage healthcare providers to adopt REBOA as a standard practice in trauma care. In June 2024, Emergency Scientific, a Utah-based firm, announced the first use of its Landmark REBOA catheter, following its FDA 510(k) clearance. This device is for temporary occlusion of large vessels in emergency hemorrhage control. The Landmark catheter is designed to enhance the precision of occlusion while minimizing complications associated with traditional methods.

There is an increasing awareness among healthcare professionals regarding the benefits of REBOA in managing traumatic hemorrhage. Alongside this awareness, specialized training programs are being developed to educate clinicians on the proper use of REBOA techniques. This growing emphasis on education ensures that more healthcare providers are equipped with the knowledge and skills necessary to implement this life-saving procedure effectively. In March 2024, an article was published in the Journal of Emergency Medicine detailing A Pilot Study on A Novel REBOA Training Curriculum designed for Emergency Medicine Residents. This cutting-edge curriculum was designed to advance the competencies and understanding of Emergency Medicine residents in applying the REBOA technique, with the aim of bettering patient outcomes in life-threatening scenarios.

The regulatory environment surrounding medical devices has become increasingly supportive of innovative solutions like REBOA. Regulatory bodies are recognizing the importance of rapid intervention techniques in trauma care and are streamlining approval processes for new devices. This supportive stance encourages manufacturers to invest in research and development, further propelling market growth. In February 2024, Neurescue announced that it raised USD 7.27 million in a Series A funding round. This investment was spearheaded by West Hill Capital, a London-based investment firm.

Global Resuscitative Endovascular Balloon Occlusion Of The Aorta Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global resuscitative endovascular balloon occlusion of the aorta market report based on end-use, and region:
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Cardiac Arrest
  • Aortic Occlusion
  • Tactical Combat Casualty Care
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Asia Pacific
  • China
  • Japan

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. End Use
1.2.2. Regional scope
1.2.3. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. End Use outlook
2.2.2. Regional outlook
2.3. Competitive Insights
Chapter 3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidence of trauma cases
3.2.1.2. Technological advancements
3.2.1.3. Growing awareness and training programs
3.2.1.4. Military applications
3.2.2. Market restraint analysis
3.2.2.1. Cost considerations
3.2.2.2. Regulatory challenges
3.3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Estimates & Trend Analysis
4.1. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Dashboard
4.2. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Movement Analysis
4.3. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Estimates and Forecasts, by End Use, Revenue (USD Million)
4.4. Cardiac Arrest
4.4.1. Cardiac arrest market estimates and forecasts 2018 to 2030 (USD Million)
4.5. Aortic Occlusion
4.5.1. Aortic occlusion market estimates and forecasts 2018 to 2030 (USD Million)
4.6. Tactical Combat Casualty Care
4.6.1. Tactical combat casualty care market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: Regional Estimates & Trend Analysis by Application, Type, and End Use
5.1. Regional Dashboard
5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.3. North America
5.3.1. U.S.
5.3.1.1. Key country dynamics
5.3.1.2. Regulatory framework/ reimbursement structure
5.3.1.3. Competitive scenario
5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Canada
5.3.2.1. Key country dynamics
5.3.2.2. Regulatory framework/ reimbursement structure
5.3.2.3. Competitive scenario
5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
5.4. Europe
5.4.1. UK
5.4.1.1. Key country dynamics
5.4.1.2. Regulatory framework/ reimbursement structure
5.4.1.3. Competitive scenario
5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
5.4.2. Germany
5.4.2.1. Key country dynamics
5.4.2.2. Regulatory framework/ reimbursement structure
5.4.2.3. Competitive scenario
5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. France
5.4.3.1. Key country dynamics
5.4.3.2. Regulatory framework/ reimbursement structure
5.4.3.3. Competitive scenario
5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
5.4.4. Italy
5.4.4.1. Key country dynamics
5.4.4.2. Regulatory framework/ reimbursement structure
5.4.4.3. Competitive scenario
5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
5.4.5. Spain
5.4.5.1. Key country dynamics
5.4.5.2. Regulatory framework/ reimbursement structure
5.4.5.3. Competitive scenario
5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
5.5. Asia Pacific
5.5.1. Japan
5.5.1.1. Key country dynamics
5.5.1.2. Regulatory framework/ reimbursement structure
5.5.1.3. Competitive scenario
5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
5.5.2. China
5.5.2.1. Key country dynamics
5.5.2.2. Regulatory framework/ reimbursement structure
5.5.2.3. Competitive scenario
5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Company/Competition Categorization
6.2. Vendor Landscape
6.2.1. List of key distributors and channel partners
6.2.2. Key customers
6.2.3. Key company market share analysis, 2023
6.2.4. Prytime Medical Devices, Inc
6.2.4.1. Company overview
6.2.4.2. Financial performance
6.2.4.3. Product benchmarking
6.2.4.4. Strategic initiatives
6.2.5. NEURESCUE
6.2.5.1. Company overview
6.2.5.2. Financial performance
6.2.5.3. Product benchmarking
6.2.5.4. Strategic initiatives
6.2.6. Emergency Scientific, LLC
6.2.6.1. Company overview
6.2.6.2. Financial performance
6.2.6.3. Product benchmarking
6.2.6.4. Strategic initiatives
6.2.7. Qx Médical
6.2.7.1. Company overview
6.2.7.2. Financial performance
6.2.7.3. Product benchmarking
6.2.7.4. Strategic initiatives
6.2.8. Front Line Medical Technologies
6.2.8.1. Company overview
6.2.8.2. Financial performance
6.2.8.3. Product benchmarking
6.2.8.4. Strategic initiatives
6.2.9. Reboa Medical As
6.2.9.1. Company overview
6.2.9.2. Financial performance
6.2.9.3. Product benchmarking
6.2.9.4. Strategic initiatives
List of Tables
Table 1 List of abbreviation
Table 2 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
Table 3 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 4 U.S. resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 5 Canada resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 6 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
Table 7 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 8 Germany resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 9 UK resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 10 France resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 11 Italy resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 12 Spain resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 13 Asia Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
Table 14 Aisa Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 15 China resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
Table 16 Japan resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: market outlook
Fig. 9 Resuscitative endovascular balloon occlusion of the aorta (REBOA) competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market driver impact
Fig. 13 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market restraint impact
Fig. 14 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use movement analysis
Fig. 15 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use outlook and key takeaways
Fig. 16 Cardiac arrest market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Aortic occlusion market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Tactical combat casualty care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional movement analysis
Fig. 20 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional outlook and key takeaways
Fig. 21 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market share and leading players
Fig. 22 North America, by country
Fig. 23 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 U.S. key country dynamics
Fig. 25 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Canada key country dynamics
Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 UK key country dynamics
Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Germany key country dynamics
Fig. 32 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 France key country dynamics
Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Italy key country dynamics
Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Spain key country dynamics
Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 China key country dynamics
Fig. 41 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Japan key country dynamics
Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)

Companies Mentioned

  • Prytime Medical Devices, Inc.
  • NEURESCUE
  • Emergency Scientific, LLC
  • Qx Médical
  • Front Line Medical Technologies
  • Reboa Medical As

Methodology

Loading
LOADING...

Table Information